Giroctocogene Fitelparvovec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Giroctocogene Fitelparvovec, covering 2026-04-07 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively [Phase 3]